The Behavioural Response to the 5-hydroxytryptamine_1B, (5HT_1B) Receptor Agonist—Ru-24969 May Exhibit a Orcadian Variation in the Mouse

References

• Quay W. B. Difference in circadian rhythms in 5HT according to brain region. Am J Physiol 1968; 215: 1448–1453
   PubMed Web of Science ®Google Scholar
• Morgan W. W., Yndo C. A. Daily rhythms in tryptophan and serotonin content in the mouse brain: the apparent independence of these parameters from daily changes in food intake and from plasma tryptophan content. Life Sci 1973; 12(Part II)395–408
   Google Scholar
• Faradji H., Cespuglio R., Jouvet M. Voltammetric measurements of 5-hydroxyindole compounds in the suprachiasmatic nucleus of the rat: circadian fluctuations. Brain Res 1983; 297: 111–119
   Google Scholar
• Martin K. F., Marsden C. A. Circadian rhythms in the CNS. In vivo. diurnal variations of 5HT release in hypothalamic nuclei. In: Redfern P. H, Davis, JA 1985; 81–93, Macmillan London
   Google Scholar
• Bruinink A., Lichtensteiger W., Schlumpf M. Ontogeny of diurnal rhythms of central dopamine, serotonin and spirodecanone binding sites and of motor activity in the rat. Life Sci 1983; 33: 31–38
   PubMed Web of Science ®Google Scholar
• Mason R. Effect of chronic constant illumination on the responsiveness of rat suprachiasmatic, lateral geniculate and hippocampal neurones to ionophoresed 5HT. J Physiol 1984; 357, (London) 13P
   Web of Science ®Google Scholar
• Moser P. C., Redfern P. H. Diurnal variation in behavioural responses to 5HT receptor stimulation. Br J Pharmacol 1984; 82: 269P
   PubMed Web of Science ®Google Scholar
• Peroutka S. J., Snyder S. H. Multiple serotonin receptors: differential binding of [3H]-5-hydroxytryptamine, [3H]-lysergic acid diethylamide and [3H]-spiroperidol. Mol Pharmacol 1979; 16: 687–708
   PubMed Web of Science ®Google Scholar
• Pedigo N. W., Yamamura H. I., Nelson D. L. Discrimination of multiple [3H]-5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain. J. Neurochem 1981; 36: 220–226
   PubMed Web of Science ®Google Scholar
• Gardner C. R., Guy A. P. Behavioural effects of RU-24969, a 5HT1 receptor agonist, in the mouse. Br J Pharmacol 1983; 78: 96P
   Google Scholar
• Pazos A., Palacios J. M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain—1. Serotonin-I receptors. Brain Res 1985; 346: 205–230
   PubMed Web of Science ®Google Scholar
• Euvard C., Boissier J. R. Biochemical assessment of the central 5HT agonist activity of RU-24969 (a piperidinyl indole). Eur J Pharmacol 1980; 63: 65–72
   PubMed Web of Science ®Google Scholar
• Middlemiss D. N. The putative 5HT, receptor agonist, RU-24969, inhibits efflux of 5-hydroxytryptamine from rat frontal cortex slices by stimulation of the 5HT autoreceptor. J Pharm Pharmacol 1985; 37: 434–437
   PubMed Web of Science ®Google Scholar
• Brazell M. P., Marsden C. A., Nisbet A. P., Routledge C. The 5HT1 receptor agonists RU-24969 decreases 5-hydroxy-tryptamine (5HT) release and metabolism in the rat frontal cortex in vitro and in vivo. Br J Pharmacol 1985; 86: 209–216
   PubMed Web of Science ®Google Scholar
• Martin K. F., Marsden C. A. In vivo 1986, voltammetry in the suprachiasmatic nucleus of the rat: effects of RU4969, methiothepin and ketanserin. Eur J. Pharmacol (in press.
   Google Scholar
• Marsden C. A., Martin K. F. RU 24969 decreases 5HT release in the SCN by acting on 5HT receptors in the SCN but not the dorsal raphe. Br J Pharmacol 1985; 85: 219P
   Google Scholar
• Green A. R., Guy A. P., Gardner C. R. The behavioural effects of RU-24969, a 5HT1 receptor agonist, in rodents and the effects of these behaviours of various antidepressant treatments. Neuropharmacology 1984; 23: 655–663
   PubMed Web of Science ®Google Scholar
• Nisbet A., Marsden C. A. Increased behavioural response to 5-methoxy-N. N-dimethyltryptamine but not to RU-24969 after intraventricular 5,7-dihydroxytryptamine administration. Eur J Pharmacol 1984; 104: 177–180
   PubMed Web of Science ®Google Scholar
• Blackburn T. P., Kemp J. D., Martin D. A., Cox B. Evidence that 5HT agonist-induced rotational behaviour in the rat is mediated via 5HT1 receptors. Psychopharmacology 1984; 63: 163–185
   Google Scholar
• Gardner C. R. Pharmacological studies of the role of serotonin in animal models of anxiety. Neuropharmacology of Serotonin, A. R. Green. Oxford University Press, Oxford 1985; 281–285
   Google Scholar
• Tricklebank M. D. Is hyperlocomotion induced by the 5HT1 agonist, 5-methoxy-3 (1, 2, 3, 6-tetrahydropyridin-4-yL)-IH-indole (RU-24969)?. Br J Pharmacol 1984; 81: 88P
   Google Scholar
• Moser P. C., Redfern P. H. Behavioural parameters of 5HT1 receptor stimulation do not show circadian variation. Br J Pharmacol 1985; 86: 461P
   Google Scholar
• Deakin J. F. W., Dashwood M. R. The differential neurochemical basis of the behaviours elicited by scrotoninergic agents and by the combination of a monoamine oxidase inhibitor and l-DOPA. Neuropharmacology 1981; 20: 123–130
   PubMed Web of Science ®Google Scholar
• Leysen J. E., Awonters F., Kennis L., Laduron P. M., Venderberk J., Janssen P. A. J. Receptor binding profile of R 41 468, a novel antagonist at 5HT2 receptors. Life Sci 1981; 28: 1015–1022
   PubMed Web of Science ®Google Scholar
• Kafka M. S., Wirg-Justice A., Naber D., Moore R. Y., Benedito M. A. Circadian rhythms in rat brain neurotransmitter receptors. Fed Proc 1983; 42: 2796–2801
   PubMedGoogle Scholar
• Dunn J. D., Johnson P. C., Castro A. J. The effect of raphe transection on circadian patterns of serum corticosterone. Neuroendocrinol Lett 1983; 5: 233–238
   Web of Science ®Google Scholar